Cost · checked August 2026
No 1-month price
No price for one month with no commitment appears on their public pages. Every figure they do publish is below.
| Plan | Per month | Charged today |
|---|---|---|
| 12-month plan, paid annually · advertised | $99.99 | $1,199.88 |
The only rung on the site that carries a stated term is in the comparison table: "Compound Semaglutide ... Price Starting at $99 99 /mo (Paid Annually)". RxPros does not print an annual total, so the charged-today figure above is $99.99 multiplied by twelve rather than a number RxPros states. The same medication is priced three other ways on the same page — "$ 99 99 A Month*" in the hero, "Semaglutide Now only $149 *" mid-page and "Semaglutide $ 134 99 /month *" lower down — and the asterisk under two of those reads "*First month Introductory Discount for all new patients or save big when paid quarterly." No quarterly figure is published. Quantity is stated as "4 Weekly Injections".
| Plan | Per month | Charged today |
|---|---|---|
| 12-month plan, paid annually | $144.97 | $1,739.64 |
"Compound Tirzepatide ... Price Starting at $144 97 /mo (Paid Annually)", again with no total printed, so $1,739.64 is that figure times twelve. Tirzepatide appears elsewhere on the same page as "$ 144 97 A Month*", "Tirzepatide Now only $249 *" and "Tirzepatide $ 224 99 /month *".
The hero prints "Semaglutide $ 99 99 A Month*" and "Tirzepatide $ 144 97 A Month*". A block halfway down says "Tirzepatide Now only $249 * Semaglutide Now only $149 *". A pair of cards below that says "$ 134 99 /month *" and "$ 224 99 /month *". A comparison table at the foot says "Starting at $99 99 /mo (Paid Annually)" and "Starting at $144 97 /mo (Paid Annually)".
Two of those readings can be reconciled. The comparison table tells you what the hero does not: $99.99 and $144.97 are annual rates. The asterisk under the $149 and $249 pair tells you the rest — "*First month Introductory Discount for all new patients or save big when paid quarterly." What's left unexplained is $134.99 and $224.99, which carry the same asterisk and match neither the annual rate nor the introductory one.
The thing none of those numbers says is that you can't buy one month. RxPros's own FAQ: "In order to give you the lowest prices in the industry we ALWAYS send a 3 month supply of the medication with syringes and alcohol swabs." Their returns page is blunter: "Programs involving the use of Semaglutide, Tirzepatide, or similar GLP-1 medications require a three-month minimum commitment, as three months' worth of medication is dispensed upfront. Customers enrolling in these programs agree to the full three-month term, regardless of payment frequency."
That sits directly against the home page's own bullet, "Cancel Subscription Anytime". The returns page says cancellation is available "ONLY AFTER the minimum term has been concluded (3 month minimum AND/OR 6/12 months if longer plan is selected)", and that leaving early "will result in a fee equal to the full retail monthly price of the remaining commitment." Two paragraphs earlier the same page says "Cancellation may be completed at any time via RXPros’ secure dashboard", which is the opposite.
There is one more charge that appears nowhere near a price: "$150 reprocessing fee" for a modification requested after the prescription has gone to the pharmacy. Because RxPros publishes no per-month figure for the three-month plan it actually sells, we have marked this record for a funnel walk and we're not printing a month-to-month number we can't source.
The rest of the review — what the service is like and who should skip it — is on the RxPros review. Prices move; this page was read August 2026, and the company's own site is the current source.
To see every plan above priced out line by line — the rate, any required membership, any published consultation fee, and what a prepay term charges today — use the real cost calculator. It reads the same ladder this page does, so the two cannot disagree.
RxPros is not a partner. We link to them from the review and earn nothing from it.
More reviews on the index; the rules behind them are on how we review, written by Kevin Turner.